B7S1, a novel candidate for anti-tumor checkpoint blockade immunotherapy.

Tytuł:: B7S1, a novel candidate for anti-tumor checkpoint blockade immunotherapy.
Autorzy:: Chen X; Institute of Immunology, Third Military Medical University, Chongqing, 400038, China.
Ye L; Institute of Immunology, Third Military Medical University, Chongqing, 400038, China. .
Źródło:: Science China. Life sciences [Sci China Life Sci] 2018 Sep; Vol. 61 (9), pp. 1132-1134. Date of Electronic Publication: 2018 Jun 21.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Beijing : Science China Press, co-published with Springer
MeSH Terms:: Immunotherapy/*methods
Neoplasms/*immunology
Neoplasms/*therapy
V-Set Domain-Containing T-Cell Activation Inhibitor 1/*immunology
CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Humans ; Ligands ; Models, Immunological ; Neoplasms/metabolism ; Programmed Cell Death 1 Receptor/immunology ; Programmed Cell Death 1 Receptor/metabolism ; V-Set Domain-Containing T-Cell Activation Inhibitor 1/metabolism
Substance Nomenclature:: 0 (Ligands)
0 (Programmed Cell Death 1 Receptor)
0 (V-Set Domain-Containing T-Cell Activation Inhibitor 1)
0 (VTCN1 protein, human)
Entry Date(s):: Date Created: 20180803 Date Completed: 20181211 Latest Revision: 20181211
Update Code:: 20240105
DOI:: 10.1007/s11427-018-9321-0
PMID:: 30069671
: Czasopismo naukowe

Full Text Finder

Informacja